The cost of multiple myeloma and its complications: a single-center study from Oran, Algeria

CONCLUSION: A number of adjustments have been implemented to the management of MM over time to improve clinical efficacy and reduce costs in Algeria. However, this may have come with a startlingly high cost of complications.PMID:38340806 | DOI:10.1016/j.pharma.2024.02.001

Source: Annales Pharmaceutiques Francaises - February 10, 2024 Category: Drugs & Pharmacology Authors: Fairouz Haouatti Ikram K Belhadj Ahlem Goumidi Nabil Yafour Toumi Houari Source Type: research